11:12 AM EST, 12/20/2024 (MT Newswires) -- European equities traded in the US as American depositary receipts were dropping sharply late Friday morning, falling 1.89% to 1,275.63 on the S&P Europe Select ADR Index, which is down 4.6% for the week.

From continental Europe, the gainers were led by furniture maker Natuzzi (NTZ) and telecommunications company VEON (VEON), which advanced 8.4% and 3.4%, respectively. They were followed by medical device maker EDAP TMS ( EDAP ) and biotech firm BioNTech (BNTX), which increased 1.9% and 1.3%, respectively.

The decliners from continental Europe were led by pharmaceutical company Novo Nordisk ( NVO ) and accommodations booking company trivago (TRVG), which fell 20% and 5.3%, respectively. They were followed by biopharmaceutical company Cellectis ( CLLS ) and 3D printer company Materialise (MTLS), which were down 2.1% and 1.7%, respectively.

From the UK and Ireland, the gainers were led by biotech firm Autolus Therapeutics ( AUTL ) and cruise line operator Carnival (CUK), which rose 3.8% and 3.3%, respectively. They were followed by biopharmaceutical company Biodexa Pharmaceuticals ( BDRX ) and pharmaceutical company Silence Therapeutics ( SLN ) , which were up 2.7% and 2.6%, respectively.

The decliners from the UK and Ireland were led by biopharmaceutical company Mereo BioPharma Group ( MREO ) and software firm Endava ( DAVA ) , which were down 2.4% and 1.6%, respectively. They were followed by biotech firm Trinity Biotech ( TRIB ) and alcoholic beverage company Diageo ( DEO ) , down 1.2% and 1%, respectively.